Board Meeting Details
The Board of Directors meeting was held on Thursday, August 13, 2026, commencing at 3:00 PM and concluding at 3:40 PM. The meeting approved the Un-Audited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026, along with the draft Limited Review Report pursuant to Regulation 33 of SEBI Listing Regulations.
Trading Window Closure
The Trading Window for dealing in shares of the Company was closed for all Directors/KMPs/Designated Employees/Connected Persons from July 01, 2026, and remained closed up to 48 hours after the declaration of financial results for the quarter ended June 30, 2026, in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Internal Procedures and Conduct.
Standalone Financial Results (Rs. in Lakhs)
Income Statement Highlights:
- Revenue from Operations: ₹61.61 lakh (Q1 FY27) vs ₹33.68 lakh (Q1 FY26)
- Jewellery Business: ₹45.00 lakh (Q1 FY27) vs ₹15.00 lakh (Q1 FY26)
- Pharmaceutical Business: ₹0.00 lakh (Q1 FY27) vs not specified (Q1 FY26)
- Other Income: ₹16.61 lakh (Q1 FY27) vs ₹18.68 lakh (Q1 FY26)
- Total Income: ₹61.61 lakh (Q1 FY27) vs ₹33.68 lakh (Q1 FY26)
Expense Breakdown:
- Employee benefits expense: ₹4.81 lakh
- Finance costs: ₹0.70 lakh
- Depreciation: ₹0.12 lakh
- Other expenses: ₹245.88 lakh
- Total Expenses: ₹251.51 lakh
Profit/Loss:
- Loss before exceptional items and tax: ₹(189.90) lakh vs profit of ₹12.47 lakh (Q1 FY26)
- Exceptional items: ₹0.00 lakh
- Loss before tax: ₹(189.90) lakh vs profit of ₹12.47 lakh (Q1 FY26)
- Tax expenses: ₹0.00 lakh
- Loss for the period: ₹(189.90) lakh vs profit of ₹9.33 lakh (Q1 FY26)
- Other Comprehensive Income: ₹689.02 lakh
- Total Comprehensive Income: ₹499.12 lakh
Capital Structure:
- Paid-up equity share capital: ₹1,441.50 lakh (face value of ₹1/- each)
- Reserves and Surplus: ₹4,416.82 lakh
- Basic & Diluted EPS: ₹(0.13) vs ₹0.02 (Q1 FY26)
Consolidated Financial Results (Rs. in Lakhs)
Income Statement Highlights:
- Revenue from Operations: ₹45.00 lakh
- Jewellery Business: ₹45.00 lakh
- Pharmaceutical Business: ₹0.00 lakh
- Other Income: ₹16.61 lakh
- Total Income: ₹61.61 lakh
Expense Breakdown:
- Employee benefits expense: ₹4.81 lakh
- Finance costs: ₹0.70 lakh
- Depreciation: ₹0.12 lakh
- Other expenses: ₹245.88 lakh
- Total Expenses: ₹251.51 lakh
Profit/Loss:
- Loss before exceptional items and tax: ₹(189.90) lakh
- Exceptional items: ₹0.00 lakh
- Share of Loss from Associate Company: ₹(24.92) lakh
- Loss before tax: ₹(214.82) lakh
- Tax expenses: ₹0.00 lakh
- Loss for the period: ₹(214.82) lakh
- Other Comprehensive Income: ₹689.02 lakh
- Total Comprehensive Income: ₹474.20 lakh
Capital Structure:
- Paid-up equity share capital: ₹1,441.50 lakh
- Reserves and Surplus: ₹4,392.56 lakh
- Basic & Diluted EPS: ₹(0.15)
Segment Reporting (Standalone)
The Company has two reportable segments:
1. Jewellery Business: Revenue ₹45.00 lakh for Q1 FY27
2. Pharmaceutical Business: Revenue ₹0.00 lakh for Q1 FY27
Segment Reporting (Consolidated)
The Company is engaged in two segments:
1. Jewellery Business: Revenue ₹45.00 lakh for Q1 FY27
2. Pharmaceutical Business: Revenue ₹0.00 lakh for Q1 FY27
Auditor Review
V R S K & CO. LLP, Chartered Accountants (Firm Regn. No: 111426W/W100988) reviewed both standalone and consolidated financial results. Their review concluded that nothing has come to their attention that causes them to believe that the statements contain any material misstatement.
Additional Information
- The results were reviewed by the Audit Committee and approved by the Board of Directors
- Figures of previous periods have been regrouped wherever necessary
- During the quarter, there were no complaints from investors
- The consolidated results include the financials of Ferry Automotive Private Limited as an Associate Company